Human Hair Germinal Matrix Cells (HHGMC)

Cat.No.: CSC-7775W

Species: Human

Source: Hair Follicle

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-7775W
Description
HHGMC from Creative Bioarray are isolated from germinal matrix of hair follicle bulbs. HHGMC are cryopreserved at passage one culture and delivered frozen. Each vial contains >5 x 10^5 cells in 1 ml volume. HHGMC are characterized by their mesenchymal cell morphology and immunofluorescent method with antibody to fibronectin and CD105. HHGMC are negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast and fungi. HHGMC are guaranteed to further expand for 5 population doublings at the condition provided by Creative Bioarray.
Species
Human
Source
Hair Follicle
Disease
Normal
Storage and Shipping
Directly and immediately transfer cells from dry ice to liquid nitrogen upon receiving and keep the cells in liquid nitrogen until cell culture needed for experiments.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Human Gastric Smooth Muscle Cells (HGSMC) are primary smooth muscle cells isolated from human stomach that closely recapitulate many aspects of gastrointestinal motility as well as gastric smooth muscle function in vivo. Thus, HGSMC provide an important physiologically relevant tool for gastrointestinal biology and translational research.

HGSMC possess a classic spindle-shaped elongated morphology and adhere to grow as monolayers in culture. They express smooth muscle-specific markers such as α-smooth muscle actin (α-SMA), smooth muscle myosin heavy chain, and calponin verifying their contractile nature. Furthermore, HGSMC respond to neurotransmitters, hormones and pharmacological agents known to regulate gastric motility such as acetylcholine, nitric oxide-mediated signaling pathways and calcium-dependent cell activation.

HGSMCs have been utilized extensively to study mechanisms associated with gastric motility disorders such as gastroparesis, functional dyspepsia, inflammation-induced or metabolic disease associated gastric smooth muscle dysfunction. These cells are also commonly employed to assess novel prokinetic or antispasmodic drug targets. HGSMC can additionally be used to study smooth muscle proliferation, phenotypic switch and extracellular matrix remodeling.

Novel Effect of Hyaluronan and Proteoglycan Link Protein 1 (HAPLN1) on Hair Follicle Cells Proliferation and Hair Growth

Current hair-loss drugs are hampered by limited efficacy and significant side-effects. Ha et al. asked whether recombinant human hyaluronan- and proteoglycan-link protein 1 (rhHAPLN1), an extracellular-matrix stabiliser, can safely accelerate hair cycling and promote matrix-cell proliferation.

To examine HAPLN1's role in hair cell proliferation, human hair germinal matrix cells (HHGMC) were treated with rhHAPLN1 and/or HA. Both significantly promoted TGF-β2-dependent proliferation (Fig. 1D). HAPLN1 co-localized with TβRII in the highly proliferative anagen hair matrix (Fig. 1E), suggesting HAPLN1 is essential for proliferation. Western blotting showed rhHAPLN1 (20 ng/mL) increased TβRII levels, with further enhancement when combined with HA (Fig. 2A, B), likely through formation of a PGs-rhHAPLN1-HA-CD44-TβRII complex that prevents TβRII endocytic degradation. HAPLN1 knockdown reduced endogenous TβRII levels, which were restored by rhHAPLN1/HA treatment (Fig. 2C, D), confirming HAPLN1 maintains TβRII expression. Using 4-MU (HAS2 inhibitor) to test HA dependence, they found 4-MU decreased TβRII and HAS2 levels, while rhHAPLN1 restored both (Fig. 2E), indicating HA contributes to TβRII stabilization through HAPLN1.

Expression of HAPLN1 indifferent stages of hair growth cycle and HAPLN1 enhanced the proliferation of HHGMCs.

Fig. 1. Expression of HAPLN1 indifferent stages of hair growth cycle and HAPLN1 enhanced the proliferation of HHGMCs (Ha HC, Zhou D, et al., 2023).

rhHAPLN1 and/or HA increased TβRII levels expression in HHGMCs.

Fig. 2. rhHAPLN1 and/or HA increased TβRII levels expression in HHGMCs (Ha HC, Zhou D, et al., 2023).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products